Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Terminated1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT00587223Phase 3Terminated
Safety and Efficacy of Apligraf in Nonhealing Wounds of Subjects With Junctional or Dystrophic Epidermolysis Bullosa (EB)
Epidermolysis Bullosa DystrophicaEpidermolysis Bullosa, Junctional
Principalinvestigator

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of Miami

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Alexandra DJ Mancini, MSc

InMed Pharmaceuticals Inc.

Moderately Similar
1 trials

Shared therapeutic areas:

Epidermolysis Bullosa DystrophicaEpidermolysis Bullosa, Junctional
Similarity Score30%

Mary Spellman

Castle Creek Pharmaceuticals, LLC

Moderately Similar
1 trials

Shared therapeutic areas:

Epidermolysis Bullosa DystrophicaEpidermolysis Bullosa, Junctional
Similarity Score30%

Christine Bodemer, MD, PhD

Hopital Necker - enfants malades

Moderately Similar
1 trials

Shared therapeutic areas:

Epidermolysis Bullosa DystrophicaEpidermolysis Bullosa, Junctional
Similarity Score30%

Joyce M Teng, MD, PhD

Stanford University

Moderately Similar
1 trials

Shared therapeutic areas:

Epidermolysis Bullosa DystrophicaEpidermolysis Bullosa, Junctional
Similarity Score30%

Damien Bates, MD, PhD, FRACS (Plast.)

Organogenesis Inc.

Related
3 trials

Shared therapeutic areas:

Epidermolysis Bullosa DystrophicaEpidermolysis Bullosa, Junctional

Worked with same sponsors:

Organogenesis
Collaborated on 1 trial
Similarity Score24%

Johann W Bauer, Prof., MD

Department of Dermatology, Paracelsus Medical University, Salzburger Landeskliniken

Related
1 trials

Shared therapeutic areas:

Epidermolysis Bullosa Dystrophica
Similarity Score15%

Alfred T Lane

Stanford University

Related
2 trials

Shared therapeutic areas:

Epidermolysis Bullosa Dystrophica
Similarity Score15%

Hal Landy, MD

Lotus Tissue Repair, Inc.

Related
1 trials

Shared therapeutic areas:

Epidermolysis Bullosa Dystrophica
Similarity Score15%

Masoud Soleimani, Prof

Shahid Beheshti University of Medical Sciences

Related
1 trials

Shared therapeutic areas:

Epidermolysis Bullosa Dystrophica
Similarity Score15%

Herbert B Slade, MD

Healthpoint

Related
18 trials

Shared therapeutic areas:

Epidermolysis Bullosa Dystrophica
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00587223Phase 3PrincipalInvestigator

Safety and Efficacy of Apligraf in Nonhealing Wounds of Subjects With Junctional or Dystrophic Epidermolysis Bullosa (EB)

Epidermolysis Bullosa DystrophicaEpidermolysis Bullosa, Junctional
Terminated

All 1 trials loaded